BioLargo, Inc.
BLGO
$0.13
-$0.01-5.00%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.12M | 617.00K | 1.10M | 2.78M | 3.27M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.12M | 617.00K | 1.10M | 2.78M | 3.27M |
| Cost of Revenue | 657.00K | 489.00K | 731.00K | 1.36M | 1.78M |
| Gross Profit | 458.00K | 128.00K | 372.00K | 1.42M | 1.49M |
| SG&A Expenses | 2.76M | 3.47M | 6.94M | 2.69M | 2.56M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.32M | 4.61M | 8.28M | 4.58M | 5.13M |
| Operating Income | -3.20M | -4.00M | -7.18M | -1.80M | -1.86M |
| Income Before Tax | -3.41M | -4.14M | -7.24M | -1.88M | -1.92M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.41M | -4.14M | -7.24M | -1.88M | -1.92M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 1.12M | 1.19M | 765.00K | 690.00K | 766.00K |
| Net Income | -2.29M | -2.95M | -6.48M | -1.19M | -1.16M |
| EBIT | -3.20M | -4.00M | -7.18M | -1.80M | -1.86M |
| EBITDA | -3.14M | -3.96M | -7.15M | -1.78M | -1.80M |
| EPS Basic | -0.01 | -0.01 | -0.02 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 |
| EPS Diluted | -0.01 | -0.01 | -0.02 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 318.70M | 314.29M | 308.97M | 303.20M | 301.27M |
| Average Diluted Shares Outstanding | 318.70M | 314.29M | 308.97M | 303.20M | 301.27M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |